|
1.
|
Aznar S, Valeron PF, Rincon SV, Perez LF,
Perona R and Lacal JC: Simultaneous tyrosine and serine
phosphorylation of Stat3 transcription factor is involved in a Rho
GTPase oncogenic transformation. Mol Biol Cell. 12:3282–3294. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Mackay D J and Hall A: Rho GTPases. J Biol
Chem. 273:20685–20688. 1998.PubMed/NCBI
|
|
3.
|
Sahai E and Marshall CJ: Rho-GTPases and
cancer. Nat Rev Cancer. 2:133–142. 2002. View Article : Google Scholar
|
|
4.
|
Van Aelst L and D’Souza-Schorey C: Rho
GTPases and signaling networks. Gene Dev. 11:2295–2322.
1997.PubMed/NCBI
|
|
5.
|
Pruitt K and Der CJ: Ras and rho
regulation of the cell cycle and oncogenesis. Cancer Lett.
171:1–10. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Foster R, Hu KQ, Lu Y, Nolan KM, Thissen J
and Settleman J: Identification of a novel human rho protein with
unusual properties: GTPase deficiency and in vivo farnesylation.
Mol Cell Biol. 16:2689–2699. 1996.PubMed/NCBI
|
|
7.
|
Nobes CD, Lauritzen I, Mattei MG, Paris S,
Hall A and Chardin P: A new member of the Rho family, Rnd1,
promotes disassembly of actin filament structures and loss of cell
adhesion. J Cell Biol. 141:187–197. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Riento K, Totty N, Villalonga P, Garg R,
Guasch R and Ridley AJ: RhoE function is regulated by Rock
1-mediated phosphorylation. EMBO J. 24:1170–1180. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Villalonga P, Guasch RM, Riento K and
Ridley AJ: RhoE inhibits cell cycle progression and ras-induced
transformation. Mol Cell Biol. 24:7829–7840. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Cuiyan Z, Jie H, Fang Z, Kezhi Z, Junting
W, Susheng S, Xiaoli F, Ning L, Xinhua M and Zhaoli C:
Overexpression of RhoE in non-small cell lung cancer (NSCLC) is
associated with smoking and correlates with dna copy number
changes. Cancer Biol Ther. 6:335–342. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Ma W, Wong CC, Tung EK, Wong CM and Ng IO:
RhoE is frequently down-regulated in hepatocellular carcinoma (HCC)
and suppresses HCC invasion through antagonizing the
Rho/Rho-Kinase/Myosin phosphatase target pathway. Hepatology.
57:152–161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Katiyar P and Aplin AE: FOXD3 regulates
migration properties and Rnd3 expression in melanoma cells. Mol
Cancer Res. 9:545–552. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Lowe SW, Schmitt EM, Smith SW, Osborne BA
and Jacks T: p53 is required for radiation-induced apoptosis in
mouse thymocytes. Nature. 362:847–849. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Lane DP: Cancer. p53, guardian of the
genome. Nature. 358:15–16. 1992. View
Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Clarke AR, Purdie CA, Harrison DJ, Morris
RG, Bird CC, Hooper ML and Wyllie AH: Thymocyte apoptosis induced
by p53-dependent and independent pathways. Nature. 362:849–852.
1993. View
Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Ongusaha PP, Kim HG, Boswell SA, Ridley
AJ, Der CJ, Dotto GP, Kim YB, Aaronson SA and Lee SW: RhoE is a
pro-survival p53 target gene that inhibits ROCK1-mediated apoptosis
in response to genotoxic stress. Curr Biol. 16:2466–2472. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Liu Y and Bodmer WF: Analysis of p53
mutations and their expression in 56 colorectal cancer cell lines.
Proc Natl Acad Sci USA. 103:976–981. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Wennerberg K, Forget MA, Ellerbroek SM,
Arthur WT, Burridge K, Settleman J, Der CJ and Hansen SH: Rnd
proteins function as RhoA antagonists by activating p190 RhoGAP.
Curr Biol. 13:1106–1115. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Etienne-Manneville S and Hall A: Rho
GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar
|
|
20.
|
Li X, Liu L, Tupper JC, Bannerman DD, Winn
RK, Sebti SM, Hamilton AD and Harlan JM: Inhibition of protein
geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis
in human endothelial cells. J Biol Chem. 277:15309–15316. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Ghosh PM, Ghosh-Choudhury N, Moyer ML,
Mott GE, Thomas CA, Foster BA, Greenberg NM and Kreisberg JI: Role
of RhoA activation in the growth and morphology of a murine
prostate tumor cell line. Oncogene. 18:4120–4130. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kamai T, Kawakami S, Koga F, Arai G,
Takagi K, Arai K, Tsujii T and Yoshida KI: RhoA is associated with
invasion and lymph node metastasis in upper urinary tract cancer.
BJU Int. 91:234–238. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Yoshioka K, Nakamori S and Itoh K:
Overexpression of small GTP-binding protein RhoA promotes invasion
of tumor cells. Cancer Res. 59:2004–2010. 1999.PubMed/NCBI
|
|
24.
|
Guasch RM, Scambler P, Jones GE and Ridley
AJ: RhoE regulates actin cytoskeleton organization and cell
migration. Mol Cell Biol. 18:4761–4771. 1998.PubMed/NCBI
|
|
25.
|
Riento K, Guasch RM, Garg R, Jin B and
Ridley AJ: RhoE binds to ROCK1 and inhibits downstream signaling.
Mol Cell Biol. 23:4219–4229. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Liu N, Bi F, Pan Y, Sun L, Xue Y, Shi Y,
Yao X, Zheng Y and Fan D: Reversal of the malignant phenotype of
gastric cancer cells by inhibition of RhoA expression and activity.
Clin Cancer Res. 10:6239–6247. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Grise F, Sena S and Bidaud-Meynard A:
Rnd3/RhoE is down-regulated in hepatocellular carcinoma and
controls cellular invasion. Hepatology. 55:1766–1775. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Luo H, Dong Z, Zou J, Zeng Q, Wu D and Liu
L: Down-regulation of RhoE is associated with progression and poor
prognosis in hepatocellular carcinoma. J Surg Oncol. 105:699–704.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Zhao H, Yang J, Fan T, Li S and Ren X:
RhoE functions as a tumor suppressor in esophageal squamous cell
carcinoma and modulates the PTEN/PI3K/Akt signaling pathway. Tumour
Biol. 33:1363–1374. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Poch E, Miñambres R, Mocholí E, Ivorra C,
Pérez-Aragó A, Guerri C, Pérez-Roger I and Guasch RM: RhoE
interferes with Rb inactivation and regulates the proliferation and
survival of the U87 human glioblastoma cell line. Exp Cell Res.
313:719–731. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Bektic J, Pfeil K, Berger AP, Ramoner R,
Pelzer A, Schafer G, Kofler K, Bartsch G and Klocker H: Small
G-protein RhoE is underexpressed in prostate cancer and induces
cell cycle arrest and apoptosis. Prostate. 64:332–340. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Trojan L, Schaaf A, Steidler A, Haak M,
Thalmann G, Knoll T, Gretz N, Alken P and Michel MS: Identification
of metastasis-associated genes in prostate cancer by genetic
profiling of human prostate cancer cell lines. Anticancer Res.
25:183–191. 2005.PubMed/NCBI
|
|
33.
|
Soussi T and Béroud C: Assessing TP53
status in human tumours to evaluate clinical outcome. Nat Rev
Cancer. 1:233–239. 2001. View Article : Google Scholar : PubMed/NCBI
|
